Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VIII.a

Lymphadenopathy (intrathoracic)

Publications

Grosu HB, Ost DE, Morice RC, Eapen GA, Li L, Song J, Lei X, Lazarus DR, Casal RF, Jimenez CA

Mediastinal Granulomatous Inflammation and Overall Survival in Patients with a History of Malignancy.

Annals of the American Thoracic Society 2015 Oct;12;1534-41 — 2015 Oct — 1534-41

Kornacker M, Kraemer A, Leo E, Ho AD

Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.

Annals of hematology 2002 Feb;81;103-5 — 2002 Feb — 103-5